Income statement revenue $570.33M (+28.9% YoY).Operating income $72.82M (-20.1% YoY).Pre-tax result $45.14M (-36.1% YoY).Net result $99.69M (-18.7% YoY).

Interventional: $211.87M (+86.1% YoY)
Surgical: $112.12M (+9.1% YoY)
Vascular Access: $246.34M (+9.0% YoY)
Selling, general and administrative expenses: $213.52M (+55.3% YoY)
Research and development expenses: $45.12M (+70.3% YoY)
Restructuring charges, separation costs and impairment charges: $246K (-97.7% YoY)
Other expense: $27.69M (+35.2% YoY)
Income tax expense: $3.38M (+35.6% YoY)
Discontinued operations (net of tax): $57.93M

Loading financials

Income statement income statement flow. Revenue $570.33M. Net result $99.69M.

Income statement revenue $570.33M (+28.9% YoY).Operating income $72.82M (-20.1% YoY).Pre-tax result $45.14M (-36.1% YoY).Net result $99.69M (-18.7% YoY).

Interventional: $211.87M (+86.1% YoY)
Surgical: $112.12M (+9.1% YoY)
Vascular Access: $246.34M (+9.0% YoY)
Selling, general and administrative expenses: $213.52M (+55.3% YoY)
Research and development expenses: $45.12M (+70.3% YoY)
Restructuring charges, separation costs and impairment charges: $246K (-97.7% YoY)
Other expense: $27.69M (+35.2% YoY)
Income tax expense: $3.38M (+35.6% YoY)
Discontinued operations (net of tax): $57.93M